On Friday, SpaceX is expected to complete the largest initial public offering in history, raising on the order of $75 billion in a single listing1 , roughly 2.5x the previous record2 . It does not arrive alone. It is the leading edge of a massive wave: the other giants of the private era, the names every allocator already knows, each preparing to ask the public markets for capital on a scale those markets have never been asked to supply.

And these are not the modest debuts of a normal cycle. They are companies that grew to enormous scale in private hands and now arrive at once, asking the same pool of capital to absorb them. A listing used to be a company tapping the market. This wave is large enough to move the market it taps. It lands on a system already working hard. I have written elsewhere about the strains the build-out places on credit. What concerns me here is different: the equity side now faces its own surge of demand at the very moment the credit side is straining to meet its own. Two pressures, one finite pool, converging.

Equity as Last Resort

Perhaps the more telling signal came weeks earlier, and from the opposite end of the spectrum. Google, part of an elite group of the highest-quality borrowers and a poster child for self-funding, raised some eighty billion dollars in equity to fund infrastructure spend and improve balance sheet quality3 . When an issuer this strong turns to equity, it signals that its reliance on debt has reached a point that needs correcting. Remember, equity is the costlier source, paid not in interest but in dilution, borne by existing holders. The shift from borrowing to issuing is not a sign of abundance, but of scarcity of supply.

Not Every Borrower is the Same Borrower

This is the distinction the market keeps collapsing, and the one that matters most. Two kinds of companies stand at the funding window. The first largely finances itself: it throws off enough cash to build what it wants, and when it does reach for outside capital, it does so on its own terms, when conditions favor it rather than when survival demands it. The second cannot build without raising money first. It arrives not by preference but by necessity.

These two are not peers, though the indices treat them as if they were. The self-funder can take or leave the market’s price; the borrower must accept it. In a market flush with money that difference is invisible, because capital is cheap for everyone and the line moves fast. It surfaces only when the line slows and the posture on rates turns.

The Strong Do Not Have to Crowd Out the Weak on Purpose 

They only have to keep doing what they were already doing. The largest technology balance sheets have become an outsized and growing share of the investment-grade market, drawing capital on terms no challenger can match. They are not trying to push anyone aside. The effect is a byproduct of strength, not a strategy, which is part of what makes it easy to overlook.

Three Windows, All Narrowing

For years the borrower had a third option. When public equity turned selective and public debt turned expensive, private credit was there, flexible and willing. That option is narrowing too. Default rates there have climbed to their highest in roughly two years, concentrated in the technology and services names this buildout tends to produce, and the more cautious lenders left standing are tightening terms at an inconvenient moment4 . Three sources of capital, all growing more selective at once.

Sedated by the Average

The surface calm belies churn underneath. By the headline measures, little looks wrong. Credit spreads sit near their tightest in three decades5 . Money flows into high-yield technology paper. The aggregate looks healthy, and the data is real.

To participants conditioned by a long calm, aggregate data sedates. An index average dictated by the strong hides the weak components. The strongest issuers come public and the marginal ones quietly withdraw, so the deals that would show stress never price. In private credit the stress is papered over directly: extend the maturity, waive the covenant, defer the payment, and a loan that should be marked down stays current. Amend and pretend. The calm is not health. It is the strain, kept out of view.

Pretending Has a Half-Life

None of this proves the system is sound; it only makes the strain easy to set aside. A market near capacity looks fine right up until it doesn’t, and is calmest just before sentiment turns.

Pretending has a half-life. Every extension is a bet that cheaper money arrives before the runway ends. For two years that was the safe bet, because the consensus held the next move in rates was down. That consensus has not just softened; it has inverted. The market that not long ago priced a series of cuts now leans toward a hike, the sharpest reversal in rate expectations since 2023, with the next Fed meeting days away. Inflation has reaccelerated, energy has spiked, the labor market has held. The extension that once bought time now only postpones the exit to a higher cost than the one the borrower already couldn’t meet.

Borrowers that depend on others’ capital eventually get crowded out, or face a cost of capital that renders their projects uneconomic. That is how a market this full resolves itself. Abundant money can chase a real thesis for years before the test arrives: the fiber boom of the late 1990s laid real cable for a real future and still left most of its borrowers impaired.

This is why I lean away from companies with significant negative free cash flow. Not out of caution, and not as a rule against ambition, but because each one depends on the same conditions holding: an accommodating cost of capital, an open window, a willing lender, a steady or falling rate. The company that funds itself needs none of them, and owes its progress to its own balance sheet rather than to anyone else’s accommodation.

It is also why I am content to let others reach for the marquee debuts of this cycle, the ones whose scale guarantees a crowd. The company that funds itself chooses its moment. The company that must raise has its moment chosen for it, on terms set by whoever holds the capital when the line stops moving.

I would rather not be standing at that window when the sedative wears off, hoping it stays open. I would rather already be inside.

Footnotes 

1 Laurence Darmiento, Business Insider, “SpaceX’s IPO is finally here. Here’s what investors need to know”, June 11, 2026.
2 Julia Horowitz and John Defterlos, CNN Business, “Saudi Aramco raises $25.6 billion in the world’s biggest IPO”, December 5, 2019.
3 Alphabet, Issuer Free Writing Prospectus (FWP) Pursuant to Rule 433, “Alphabet Announces Proposed $80 Billion Equity Capital Raise to Expand AI Infrastructure and Compute”, June 1, 2026.
4 Fitch Ratings, “U.S. Private Credit Default Rate Continues Upward March to 5.8” in January 2026, February 23, 2026.
5 Bloomberg, “AI Debt Binge Is Set to Test Credit’s 1990s-Like Euphoria”, January 22, 2026.

Important Disclosures

Securities highlighted or discussed in this blog have been selected to illustrate Validex’s investment approach and/or market outlook and are not intended to represent any strategy or portfolio performance or be an indicator for how strategy or portfolio have performed or may perform in the future. Each security discussed in this blog has been selected solely for this purpose and has not been selected on the basis of performance or any performance-related criteria. The securities discussed herein do not represent an entire portfolio and, in aggregate, may only represent a small percentage of a strategy or portfolio holdings. The strategies and portfolios are actively managed, and securities discussed in this blog may or may not be held in such strategies or portfolios at any given time. These individual securities do not represent all the securities purchased, sold, or recommended and the reader should not assume that investments in the securities identified and discussed were or will be profitable. Nothing in this blog shall constitute a recommendation or endorsement to buy or sell any security or other financial instrument referenced in this letter. 

Validus Growth Investors, LLC , dba Validex Global Investing (Validex or VGI) seeks to invest in companies at every stage of their growth. From startups to publicly traded companies, our research identifies inflection points that have the potential to produce meaningful growth and income for the clients we serve. 

Investment Advisory Services are offered through Validex, an SEC Registered Investment Adviser. No offer is made to buy or sell any security or investment product. This is not a solicitation to invest in any security or any investment product of Validex. Validex does not provide tax or legal advice. Consult with your tax advisor or attorney regarding specific situations. Intended for educational purposes only and not intended as individualized advice or a guarantee that you will achieve a desired result. Opinions expressed are subject to change without notice. Investing involves risk, including the potential loss of principal. No investment can guarantee a profit or protect against loss in periods of declining value. All information is believed to be from reliable sources; however, we make no representation as to its completeness or accuracy. Opinions and projections are as of the date of their first inclusion herein and are subject to change without notice to the reader. As with any analysis of economic and market data, it is important to remember that past performance is no guarantee of future results. 

See social media content disclosure HERE